XML 44 R7.htm IDEA: XBRL DOCUMENT v3.22.0.1
Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Cash flows from operating activities      
Net loss $ (41,567,000) $ (5,324,000) $ (1,198,000)
Adjustments to reconcile net loss to net cash used in operating activities      
Depreciation expense 249,000 8,000 0
Non-cash operating lease expense 704,000 124,000  
Stock-based compensation expense 6,234,000 322,000  
Net amortization of premiums and accretion of discounts on investments 516,000    
Changes in operating assets and liabilities:      
Prepaid expenses and other current assets (2,517,000) (472,000) 7,000
Other assets (1,218,000) (12,000)  
Accounts payable 640,000 418,000 (98,000)
Accrued expenses and other current liabilities 2,110,000 588,000 10,000
Operating lease liabilities (589,000) (111,000)  
Net cash used in operating activities (35,438,000) (4,459,000) (1,279,000)
Cash flows from investing activities      
Purchase of property and equipment (3,171,000) (51,000)  
Purchase of investments (38,492,000)    
Maturities of investments 8,308,000    
Net cash used in investing activities (33,355,000) (51,000)  
Cash flows from financing activities      
Proceeds from issuance of common stock, net of issuance costs   10,192,000 1,440,000
Proceeds from issuance of Series A convertible preferred stock, net of issuance costs   55,738,000  
Proceeds from issuance of common stock from initial public offering, net of issuance costs 152,753,000    
Proceeds from exercise of stock options and purchases under the employee stock purchase plan 468,000    
Proceeds (payment) from Paycheck Protection Program loan (36,000) 36,000  
Net cash provided by financing activities 153,185,000 65,966,000 1,440,000
Net increase in cash, cash equivalents, and restricted cash 84,392,000 61,456,000 161,000
Cash, cash equivalents, and restricted cash at the beginning of the period 61,695,000 239,000 78,000
Cash, cash equivalents, and restricted cash at the end of the period 146,087,000 61,695,000 239,000
Non-cash financing and investing activities:      
Conversion of Series A convertible preferred stock into common stock 55,735,000    
Acquisition of operating lease right-of-use assets 3,216,000 334,000  
Acquisition of property and equipment included in accounts payable and accrued liabilities   38,000  
Unpaid deferred offering costs   29,000  
Reconciliation of cash, cash equivalents, and restricted cash:      
Cash and cash equivalents 145,736,000 61,695,000 239,000
Restricted cash 351,000    
Cash, cash equivalents, and restricted cash at the end of the period $ 146,087,000 $ 61,695,000 $ 239,000